Literature DB >> 6319055

SLE like syndrome and functional deficiency of C1q in members of a large family.

A J Hannema, J C Kluin-Nelemans, C E Hack, A J Eerenberg-Belmer, C Mallée, H P van Helden.   

Abstract

Two sisters and a brother from one family are described whose sera were deficient in haemolytic complement function. This defect was restored by addition of purified C1q. In their sera, C1q like material was found, whereas C1r and C1s were normal or increased in concentration, as were the other complement components tested. All three had suffered from glomerulonephritis during childhood. A renal biopsy in the brother recently disclosed a membranous glomerulopathy stage 1; otherwise, he is apparently healthy. In both sisters, a systemic lupus erythematosus like disease became manifest at the age of 20 and 23, respectively, resulting in the death of one of them. In the serum of these three family members, the C1q like material was antigenically deficient compared with normal C1q and had, on sucrose gradient analysis, a molecular weight of approximately 65,000 daltons. It did not bind to C1r and C1s. Binding of the dysfunctional C1q to aggregated human gammaglobulin could be demonstrated. On double immunodiffusion analysis, the abnormal C1q was identical with reduced and alkylated C1q. The possible structure of the abnormal C1q molecule is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319055      PMCID: PMC1535777     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.

Authors:  W P Kolb; L M Kolb; E R Podack
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

2.  HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.

Authors:  F S ROSEN; J PENSKY; V DONALDSON; P CHARACHE
Journal:  Science       Date:  1965-05-14       Impact factor: 47.728

Review 3.  Complement testing in the diagnosis of immune and autoimmune diseases.

Authors:  P H Schur
Journal:  Am J Clin Pathol       Date:  1977-11       Impact factor: 2.493

Review 4.  Complement deficiency states.

Authors:  V Agnello
Journal:  Medicine (Baltimore)       Date:  1978-01       Impact factor: 1.889

5.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

6.  Clinical and immunological studies in a case of selective complete C1q deficiency.

Authors:  A I Berkel; M Loos; O Sanal; G Mauff; Y Güngen; U Ors; F Ersoy; O Yegin
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

7.  The effect of reduction and reoxidation on the biological activities and structure of human Clq (first component of complement).

Authors:  C H Heusser; M Boesman; H R Knobel; H Jacot-Guillarmod; H Isliker
Journal:  Immunochemistry       Date:  1975-03

8.  The biochemistry of complement.

Authors:  R R Porter; K B Reid
Journal:  Nature       Date:  1978-10-26       Impact factor: 49.962

9.  The effect of enzyme digestion on the antigenicity and biologic activity of Clq.

Authors:  D Wiger; J B Natvig
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

10.  Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique.

Authors:  L A Aarden; E R de Groot; T E Feltkamp
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

View more
  17 in total

Review 1.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors:  R Goldbach-Mansky
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.

Authors:  R A McAdam; D Goundis; K B Reid
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Significance of low molecular weight C1q in systemic lupus erythematosus.

Authors:  R Hoekzema; A J Swaak; M C Brouwer; A van Rooijen; E J Nieuwenhuys; C E Hack
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

4.  Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p.

Authors:  Min Ae Lee-Kirsch; Maolian Gong; Herbert Schulz; Franz Rüschendorf; Annette Stein; Christiane Pfeiffer; Annalisa Ballarini; Manfred Gahr; Norbert Hubner; Maja Linné
Journal:  Am J Hum Genet       Date:  2006-08-17       Impact factor: 11.025

5.  Segregation of lymphocyte low-molecular-weight DNA and antinuclear-antibodies in a family with systemic lupus erythematosus in first cousins.

Authors:  H Levcovitz; M A Fletcher; P Phillips; H A Chertok; R Altman; P J Benke
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

6.  Evaluation of C1q genomic region in minority racial groups of lupus.

Authors:  B Namjou; C Gray-McGuire; A L Sestak; G S Gilkeson; C O Jacob; J T Merrill; J A James; E K Wakeland; Q-Z Li; C D Langefeld; J Divers; J Ziegler; K L Moser; J A Kelly; K M Kaufman; J B Harley
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

7.  C1q nephropathy in two young sisters.

Authors:  Jameela A Kari; Sawsan M Jalalah
Journal:  Pediatr Nephrol       Date:  2007-10-21       Impact factor: 3.714

Review 8.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

9.  In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.

Authors:  R Veerhuis; L A van Es; M R Daha
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

10.  Biosynthesis of normal and low-molecular-mass complement component C1q by cultured human monocytes and macrophages.

Authors:  R Hoekzema; M C Brouwer; E R de Graeff-Meeder; H P van Helden; C E Hack
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.